Epsilon M&A Deal Report - Jennewein Biotechnologie
Transaction Multiples for the Valuation of Private Companies
Chr Hansen / Jennewein Biotechnologie
No EMAT :
102159
Announced Date :
22/09/2020
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Chr Hansen
Target :
Jennewein Biotechnologie
Country :
Germany
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Food Producers > Food & Beverage Industry > Food Complements
Business Description :
Founded in 2005 by Dr. Stefan Jennewein and Dr. Klaus Jennewein, Jennewein Biotechnologie is a biotechnology company that specializes in the development of novel production processes for sugar...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | ns | |||||||
| Current | 
|
ns |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Food Complements » = 116
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/12/2016 | Groupe Lactalis | Covalact | Romania | * | 102147 |
| 13/09/2018 | Lactalis Group | Aspen Pharmacare Global Nutritionals Business | South Africa | *** | 102136 |
Source: Epsilon Research / EMAT
